年内基金业绩排名生变：北交所、医药崛起，机器人板块退潮
【环球网金融综合报道】今年一季度，重仓机器人概念股的基金业绩一骑绝尘。进入二季度以来，行情遭遇调整，今年以来业绩领涨的基金榜单也发生较大变化，北交所主题基金和医药主题基金表现抢眼。
东方财富Choice数据显示，截至4月21日，华夏北交所创新中小企业精选两年定开混合以62.36%的收益率暂居榜首，中信建投北交所精选两年定开混合A紧随其后，收益率达61.48%。此外，汇添富北交所创新精选两年定开混合A收益率超过50%。
同时，医药主题基金也迎来了业绩的“春天”。长城医药产业精选混合发起式A以49.88%的收益率领跑医药板块，永赢医药创新智选混合发起A收益率达39.53%，华安医药生物股票发起式A同期回报为37.37%。
与北交所和医药主题基金的强势表现形成对比的是，重仓机器人概念股的基金净值出现较大回撤。以鹏华碳中和主题混合A为例，今年以来收益率一度超过80%，截至4月21日，鹏华碳中和主题混合A今年以来收益率为46.94%。同样重仓机器人板块的永赢先进制造智选混合发起A，今年以来收益率也从高点的71.2%回落至40.54%。（南木）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10